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Gene expression  is  influenced by both genetic variants and  the environment. As  individuals age,  changes  in
gene expression may be associated with decline in physical and cognitive abilities. We measured transcriptome‐
wide expression  levels  in  lymphoblastoid cell  lines derived from members of the Lothian Birth Cohort 1936 at
mean  ages  70  and  76  years.  Changes  in  gene  expression  levels were  identified  for  1,741  transcripts  in  434
individuals. Gene Ontology enrichment analysis indicated an enrichment of biological processes involved in the
immune  system.  Transcriptome‐wide  association  analysis  was  performed  for  eleven  cognitive,  fitness,  and
biomedical aging‐related traits at age 70 years (N=665 to 781) and with mortality. Transcripts for genes (F2RL3,
EMILIN1 and CDC42BPA) previously  identified as being differentially methylated or expressed  in  smoking or
smoking‐related  cancers  were  overexpressed  in  smokers  compared  to  non‐smokers  and  the  expression  of
transcripts  for  genes  (HERPUD1,  GAB2,  FAM167A  and  GLS)  previously  associated  with  stress  response,
autoimmune disease and  cancer were associated with  telomere  length. No associations between expression
levels and other traits, or mortality were identified. 
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INTRODUCTION 
 
This study investigates how gene expression levels 1) 
change within older age and 2) are associated with age-
related physical, cognitive, and biochemical traits.  
Gene expression levels are influenced by both multiple 
genetic variants and the environment. They influence 
most human traits and may provide insight into the 
biological mechanisms responsible for individual 
differences. The focus of the present study is on age-
related differences. 
 
The UK population is rapidly aging. However, little is 
known about the molecular mechanisms responsible for 
individual differences in age-related physical and 
cognitive traits [1]. As individuals age, many physical 
traits decline. Decreases in lung function, muscle 
strength, and gait speed are particularly common, and 
are associated with morbidity and mortality [2-8]. Age-
related cognitive decline is one of the most feared 
aspects of growing older, and it is highly predictive of 
dementia, morbidity and mortality [9]. 
 
Many physical traits that decline with age are heritable. 
Twin-based heritability of lung function is estimated to 
be between 39 and 54% in adults [10, 11], muscle 
strength between 40 and 65% in older adults [12, 13], 
and gait speed between 15 and 51% in older women 
[14, 15]. Recent genome-wide association (GWA) 
studies have identified genomic regions associated with 
lung function [16, 17] and grip strength (a commonly 
used measure of muscle strength) [18]. A GWA study 
of gait speed did not identify any genome-wide 
significant signals [19].  
 
Twin based heritability studies estimate the heritability 
of cognitive function to be greater than 50%, increasing 
from ~50% in childhood to as high as ~80% in middle 
adulthood and older age [20]. SNP based heritability 
was shown to be ~30% in individuals aged over 40 
years [21, 22], and a study based on 1,900 members of 
the Lothian Birth Cohorts of 1921 and 1936 and the 
Aberdeen Birth Cohort of 1936 estimated SNP based 
heritability of cognitive decline, between the ages of 11 
and 64-79 years, to be ~24% [23]. GWA studies 
indicate that both cognitive decline and cognitive ability 
are highly polygenic traits [21-25].  
 
Oxidative stress is hypothesised to contribute to age-
related physical and cognitive decline, possibly through 
increased inflammation [26] resulting in shortening of 
telomeres [27]. This may be compounded by smoking 
[28]. Telomere length is reported to decrease with age 
[29, 30] and to be influenced by smoking [28], social 
status and psychological stress [31], although its use as 
a biological marker of cognitive and physical aging is 
equivocal [30, 32, 33]. 
 
As indicated above, many age-related traits are 
heritable; however, they are also polygenic, with few 
specific genetic variants significantly contributing to 
individual differences. Moreover, they are also 
influenced by environmental and life-style factors. As 
well as trying to detect these many small and interacting 
influences per se, an attractive option is to measure an 
entity that is a summary outcome of their combined 
effects, and which might have both a more-detectable 
association with aging and be an indicator of the causal 
pathways involved. To gain further insight into the 
mechanisms leading to physical and cognitive aging, 
researchers are starting to investigate associations 
between aging-related traits and genome-wide gene 
expression levels; these are influenced by multiple 
genetic variants, methylation status, the environment, 
and gene x gene and gene x environment interactions. 
Therefore, gene expression levels capture the net 
influences on transcription and are more likely to be 
associated with age-related and other traits than are 
individual genetic variants. A meta-analysis of 7,781 
individuals aged 20-104 years, from four cohorts, 
identified 221 differentially expressed genes associated 
with muscle strength [34]. Differential gene expression 
has also been identified in smokers versus never 
smokers in a meta-analysis of 10,233 individuals from 
six cohorts [35], which may in turn influence aging. To 
the best of our knowledge, genome-wide expression 
levels have not been investigated for other aging traits. 
 
In the present study, we measured transcriptome-wide 
gene expression levels, using the Illumina HumanHT-
12v4 Expression BeadChip, in lymphoblastoid cell lines 
derived from ~800 members of the Lothian Birth 
Cohort 1936 (LBC1936) at age ~70 years and from 
~400 of the same individuals at age ~76 years. As far as 
we are aware, this is the first study to investigate 
changes in gene expression levels within older age. 
We next investigated the association of gene 
expression levels with eleven cognitive, fitness, and 





Descriptive statistics for a general fluid cognitive factor 
(gf), childhood-to-older-age IQ change, time taken to 
walk six metres, grip strength, forced expiratory volume 
from the lungs in one second (FEV1), C-reactive 
protein (CRP), fibrinogen, Glycohemoglobin (HbA1c), 
smoking status, telomere length, and mortality status are 
shown in Table 1. Individuals for whom expression data 
were available at age 70 years differed very little from 
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the whole cohort, in all measures, at age 70 years. 
Individuals for whom expression data were available at 
ages 70 and 76 years had higher general cognitive 





















































lung function, lower levels of fibrinogen, were less 
likely to have acute levels of CRP, and were less likely 
to smoke at age 70 years than those for whom only age 






















































 Full sample Individuals with age 70 expression 
data 
Individuals with age 70 and 76 
expression data 
Variable Mean (SD, range) N Mean (SD, range) N Mean (SD, range) N 
Age (years) 69.5 (0.8, 67.6-71.3) 1091 69.5 (0.8, 67.6-71.3) 781 69.5 (0.8, 67.6-
71.3) 
434 
gf 0.0 (1.0, -3.5-2.9) 1072 -0.005 (0.1, -3.0-2.9) 767 0.1 (0.1, -3.0-2.9) 429 
IQ change 0.006 (0.9, -5.6-4.4) 1016 0.005 (1.0, -5.6-4.4) 726 0.05 (0.9, -4.0-4.4) 404 
6m walk time (s) 3.8 (1.1, 1.1-11.0) 1084 3.8 (1.1, 1.1-10.9) 778 3.7 (0.9, 1.1-8.8) 433 
Grip strength (Kg) 29.0 (10.2, 2-60) 1066 29.4 (10.2, 4-60) 768 30.2 (10.0, 11-60) 427 
FEV1 (L) 2.4 (0.7, 0.5-5.1) 1085 2.4 (0.7, 0.5-5.1) 780 2.5 (0.7, 0.7-4.3) 434 
Fibrinogen (g/L) 3.3 (0.6, 1.6-6.2) 1052 3.3 (0.6, 1.6-6.2) 769 3.2 (0.6, 1.6-5.9) 428 
HbA1c (% total) 5.9 (0.7, 4.5-11.6) 1060 5.9 (0.7, 4.5-11.6) 776 5.9 (0.7, 4.5-11.6) 431 
Telomere length (kb) 4.2 (0.6, 2.7-7.1) 1070 4.2 (0.5, 2.8-7.1) 781 4.2 (0.6, 2.8-7.1) 434 
Sex  Male 548 (50%)  400 (51%)  230 (53%) 
 Female 543 (50%)  381 (49%)  204 (47%) 
CRP Normal (0.3 mg/L) 535 (51%)  401 (52%)  244 (57%) 
 Elevated (4-10 mg/L) 399 (38%)  294 (38%)  154 (36%) 
 Acute (>10 mg/L) 120 (11%)  80 (10%)  34 (8%) 
Smoking status Current smoker 125 (12%)  92 (12%)  33 (8%) 
 Past smoker 465 (43%)  325 (42%)  182 (42%) 
 Never smoker 501 (46%)  364 (47%)  219 (51%) 
Mortality status Alive 868 (80%)  627 (80%)  398 (92%) 
 Dead 223 (20%)  154 (20%)  36 (8%) 
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Expression change between ages 70 and 76 years 
 
A significant difference in expression levels between 
ages 70 and 76 years was identified for 1,741 
transcripts, with a negative T value indicating an 
increase in expression level. 874 showed an increase in 
expression and 867 a decrease in expression (Figure 1a, 
Supplementary Table 1). Figure 1b shows a density plot 
of transcript (Pearson) correlations between ages 70 and 
76 years for all transcripts and for Bonferroni corrected 
significant transcripts only. The correlations are listed in 
Supplementary Table 1. Correlations for control 
samples were all > 0.95 within plates and > 0.90 
between plates. The expression of the 1,323 probes 
significantly differentially expressed and successfully 








































the results of the cluster analysis. Cluster analysis 
separated the genes into those that increase in 
expression (cluster 1) and those that decrease in 
expression (cluster 2) between waves 1 and 3. After 
correction for 13,142 Gene Ontology (GO) terms used 
in the analysis, GO enrichment analysis using all genes 
(those showing increased and decreased expression, 
ranked by p value) indicated enrichment for six bio-
logical processes (Supplementary Table 2). The most 
significant of these were the immune system (p=3.0x10-
9), defense response (p=1.8x10-7), and positive 
regulation of the immune system (p=5.7x10-7) process-
ses. After correction for 10,471 GO terms, enrichment 
analysis using genes that showed increased expression 
indicated enrichment for protein heterotetramerization 
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for 11,220 GO terms, enrichment analysis using genes 
that showed decreased expression indicated enrichment 
for five biological processes (Supplementary Table 4). 
The most significant of these were the defense response 



















































cytokine-mediated signalling pathway (p=1.1x10-6) 
processes. As expected, there was a bias towards genes 
linked to heterodimerization in cluster 1 and a bias 
towards genes linked to defense response in cluster 2 





















































Probe  Gene symbol Chr  Beta St. Err P 
ILMN_2127298 F2RL3 19 0.11 0.019 1.57E-08 
ILMN_2390946 NA NA 0.076 0.015 2.51E-07 
ILMN_1711439 EMILIN1 2 0.095 0.019 1.30E-06 
ILMN_1781472 CDC42BPA 1 0.14 0.029 2.16E-06 
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Comparison with a previously published cross-
sectional study of genes differentially expressed with 
age 
 
Of the 1,323 differentially expressed probes mapped to 
a gene, 1,130 were assigned a unique gene symbol. 907 
of these genes were previously reported in a cross-
sectional study that identified 1,497 genes differentially 
expressed with age in the whole blood of 14,983 
individuals [36]. 244 of the 907 genes were differential-
ly expressed in this previous study (p<4.2x10-6), of 
which 113 were differentially expressed in the same 














































For the transcriptome-wide association analyses with a 
sample size of 665 (the smallest N used), we have 80% 
power (alpha=0.05, two-sided) to detect a correlation of 
0.11. Transcriptome-wide association analysis of 
current smoker versus never smoker identified four 
transcripts associated with smoking status (Figure 3a, 
Table 2). Three of the transcripts were annotated to 
genes: F2RL3 on chromosome 19 (p=1.57x10-8), 
EMILIN1 on chromosome 2 (p=1.30x10-6) and 
CDC42BPA on chromosome 1 (p=2.16x10-6). None of 













































Probe  Gene symbol Chr  Beta St. Err P 
ILMN_2374159 HERPUD1 16 0.00015 2.98E-05 7.32E-07 
ILMN_1665964 GAB2 11 7.35E-05 1.49E-05 9.81E-07 
ILMN_3248511 FAM167A 8 0.00012 2.53E-05 1.86E-06 
ILMN_2188722 GLS 2 0.00010 2.14E-05 1.92E-06 
ILMN_1687213 FAM167A 8 0.00011 2.39E-05 1.95E-06 
Figure 3. Manhattan plot of  the P‐values of  the  transcriptome‐wide  association  analyses  for  (a)  smoking  status  (current
versus never) and (b) telomere length. The red line indicates the threshold for transcriptome‐wide significance (P<2.17x10‐6).
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pressed in a large (10,233 participants) whole-blood 
transcriptome meta-analysis of current versus never 
smokers [35]. Seven of the top 10 genes in the Huan et 
al. 2016 study [35] were represented by transcripts in 
this study, of which one (PYHIN1, p=0.03) was 
nominally significantly (p<0.05) associated with smok-
ing status, but in the opposite direction (Supplementary 
Table 14). No transcripts for the top gene (LRRN3) in 
the Huan et al. 2016 study [35] passed quality control in 
our study. The full association results are shown in 
Supplementary Table 14. 
 
No transcripts were associated with former versus never 
smokers (Supplementary Table 15). Six out of the top 
10 genes in the Huan et al. 2016 study [35] were 
represented by transcripts in this study, of which two 
(RASSF1, p=0.03 and PILRA, p=0.02) were nominally 
significantly (p<0.05) associated with smoking status, 
but in the opposite direction (Supplementary Table 
15). 
 
Transcriptome-wide association identified five 
transcripts associated with telomere length (Figure 3b, 
Table 3). The transcripts were for the following genes: 
HERPUD1 on chromosome 16 (p=7.32x10-7), GAB2 on 
chromosome 11 (p=9.81x10-7), FAM167A on chromo-
some 8 (p=1.86x10-6), GLS on chromosome 2 
(p=1.92x10-6) and FAM167A on chromosome 8 
(p=1.95x10-6). The full association results are shown in 
Supplementary Table 16. 
 
No transcripts were significantly associated with gf, IQ 
change, six metre walk time, FEV1, grip strength, CRP, 
fibrinogen, HbA1c, or methylation age acceleration 
(Hannum or Horvath) (Supplementary Tables 6-13, 17-
18). Eight out of the top 10 genes for muscle strength in 
the Pilling et al. 2016 study of 7,781 participants, [34] 
were represented by transcripts in this study, of which 
one (PNP, p=0.03) was nominally significantly 
associated with grip strength at p<0.05, but in the 




Gene expression levels were not associated with 




This study has identified 1,741 transcripts that 
demonstrate a change in expression levels in lympho-
blastoid cell lines derived from 434 individuals at ages 
70 and 76 years. At age 70 years the expression levels 
of specific genes were associated with smoking status 
and telomere length. 
The findings from the GO enrichment analyses 
indicated an enrichment of biological processes 
involved in the immune system. This is consistent with 
the finding of a decline in the normal functioning of the 
immune system with age [37]. A similar number of 
genes showed increased levels of gene expression as 
showed decreased levels of gene expression with age, 
which is in line with previous findings from cross-
sectional studies [36, 38], that also identified gene 
expression changes in genes involved in immune 
processes. A look-up of the 907 genes that we showed 
to be differentially expressed with age, and were 
included in a relatively large (N=14,983) cross-sectional 
study of expression in whole blood [36], showed that 
244 were also differentially expressed in the whole 
blood study. However, only 113 were differentially 
expressed in the same direction. Discrepancies in these 
results are likely due to the different cell types sampled 
(whole blood which is a mixture of cell types versus 
LCLs), and the cross-sectional nature of the previous 
study (mean ages of cohorts included 38-72 years) 
versus the longitudinal nature of the current study (ages 
70-76 years). Our study specifically looked at change 
over a six year period in the eighth decade of life, 
whereas the previous study included many younger 
individuals. The correlation density plot (Figure 1b) of 
transcript correlations between ages 70 and 76 years 
indicated a relatively low level of stability that was 
slightly higher for transcripts for which expression 
levels significantly changed between these ages than for 
all transcripts. This may indicate that the transcripts for 
which change could be detected were more accurately 
measured. The high correlations between the control 
samples (> 0.95 within plates and > 0.90 between 
plates) indicated that overall, measurement error was 
small. 
 
The expression of three genes was upregulated in 
current versus never smokers. F2RL3, which showed 
the strongest association with smoking status, encodes a 
member of the protease-activated receptor subfamily, 
part of the G-protein coupled receptor 1 family of 
proteins that is associated with inflammation. 
Hypomethylation of F2RL3 has been associated with 
smoking status and lung cancer [39, 40]. CDC42BPA 
encodes a member of the Serine/Threonine protein 
kinase family and is upregulated in pancreatic cancer, a 
smoking related cancer, compared to normal tissue [41]. 
EMILIN1 encodes an extracellular matrix glycoprotein 
associated with elastic fibers. It has been shown to 
decrease tumor cell growth [42].  
 
None of the transcripts associated with smoking status 
in our study were identified in a previous whole-blood 
transcriptome meta-analysis, including more than 
10,000 individuals, of current versus never smokers 
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[35], and none of the top 10 hits from that study were 
nominally significant in our study. This may be due to 
the previous study investigating gene expression in 
whole blood, whereas our study investigated gene 
expression in LCLs. Our failure to replicate previously 
published associations for both smoking [35] and 
muscle strength [34]  may also be due to the smaller 
size of our study. 
 
The upregulation of expression of four genes was 
associated with longer telomere length. HERPUD1 
encodes a protein that is important in endoplasmic 
reticulum (ER) stress response. ER stress influences 
number of diseases including neurodegeneration and 
cardiovascular disease [43]. GAB2 encodes a member of 
the GRB2-associated binding protein (GAB) gene 
family and is associated with human tumorigenesis, 
particularly in breast cancer, leukemia and melanoma 
[44]. FAM167A is located in a locus previously 
associated with autoimmune diseases [45]. GLS encodes 
the K-type mitochondrial glutaminase which is 
regulated by oncogenes and supports tumor cell growth 
[46]. No genes previously associated with telomere 
length via genome-wide association studies [47-49] 
were shown to have expression levels associated with 
telomere length in this study. 
 
Strengths of this study include the longitudinal nature, 
which allowed us to investigate expression changes 
within older age. The large number of aging variables 
allowed us to investigate the association between gene 
expression levels and many cognitive and physical traits 
in older age, the majority of which had not previously 
been investigated. LBC1936 have a narrow age range 
and are genetically homogeneous, reducing variability 
that may be introduced in other cohorts.   
 
Limitations include the use of LCLs rather than whole 
blood. However, although we did not identify the same 
genes as a whole-blood transcriptome meta-analysis of 
smoking status [35], the majority of the genes that we 
did identify are known to be differentially methylated or 
expressed in smokers or smoking related cancers, 
suggesting that the results are not just artefacts 
introduced by LCL generation. Other limitations 
include the relatively short time period between the two 
waves of blood collection (~6 years), and the relatively 
small number of individuals for whom we had 
longitudinal data (n=434). The number of individuals in 
each of the transcriptome-wide associations of aging 
traits ranged from 665 to 781, which means that we had 
limited power to detect individual small associations, 
which, when combined, might predict aging-related 
traits. A further limitation is the relative good health of 
the LBC1936 participants, thus reducing the variance of 
these traits relative to the general population. In the 
future, sample sizes for this type of transcriptomic 
analysis will increase as other studies with well 
characterized aging cohorts move onto wide-range 
expression analysis.  
 
In conclusion, we identified several thousand genes 
which show either increased or decreased expression 
between ages of 70 and 76 years. These genes were 
enriched for immune system processes. In the future we 
intend to examine associations between changes in 
expression and changes in cognitive and physical traits. 
We also showed that genes previously identified as 
being differentially methylated or expressed in smoking 
or smoking-related cancers are over expressed in 
smokers compared to non-smokers in LBC1936. We 
identified a number of genes with expression levels 
associated with telomere length that have previously 
been associated with stress response, autoimmune 
disease, and cancer. Finally, we have made available 
results from the first transcriptome-wide associations of 
a number of age-related physical and cognitive traits 
that may be used in future meta-analyses of these traits. 
 
MATERIALS AND METHODS 
 
Lothian Birth Cohort 1936 (LBC1936) 
Ethics statement 
 
Investigation has been conducted in accordance with the 
ethical standards and according to the Declaration of 
Helsinki and according to national and international 
guidelines and has been approved by the authors' 
institutional review board. Ethics permission was 
obtained from the Multi-Centre Research Ethics 
Committee for Scotland (Wave 1: MREC/01/0/56), the 
Lothian Research Ethics Committee (Wave 1: 
LREC/2003/2/29), and the Scotland A Research Ethics 
Committee (Wave 3: 07/MRE00/58). All persons gave 





LBC1936 consists of 1091 (543 female) individuals, 
most of whom took part in the Scottish Mental Survey 
of 1947, during which, at the age of ~11years, they took 
the Moray House Test version 12 (MHT), a validated 
test of cognitive ability [50]. At a mean age of 69.5 
years (SD 0.8) they were recruited to a study to 
determine influences on cognitive aging [51, 52]. They 
underwent a series of cognitive and physical tests. 
Three further waves of cognitive and physical testing 
have occurred at mean ages 73, 76, and 79 years. For 
this study Peripheral Blood Mononuclear Cells 
(PBMCs) were extracted from whole blood at ages 70 
(Wave 1) and 76 (Wave 3) for the generation of 
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lymphoblastoid cell lines (LCLs) at the Edinburgh 
Clinical Research Facility (ECRF) Genetics Core, 
Western General Hospital, Edinburgh. DNA extracted 
from whole blood at age 70 was used to measure 




Physical trait measures included time taken to walk six 
metres as quickly as possible, grip strength measured 
with a Jamar Hydraulic Hand Dynamometer [all subject 
had three trials with both hands, and the best of the 
three trials in the dominant hand (self-reported) was 
used], and FEV1 measured using a microspirometer (the 




Cognitive tests included six Wechsler Adult Intelligence 
Scale-IIIUK (WAIS-III) [53] non-verbal subtests 
(matrix reasoning, letter number sequencing, block 
design, symbol search, digit symbol, and digit span 
backward). From these six cognitive tests a general 
fluid cognitive factor (gf) was derived. The scores from 
the first unrotated component of a principal components 
analysis were extracted and labelled as gf. This com-
ponent explained 52% of the variance, with individual 
test loadings ranging between 0.65 and 0.72. MHT 
scores from ages 11 and 70 were corrected for age in 
days and converted to MHT IQ-type scores (mean = 
100; SD = 15). IQ change between ages 11 and 70 years 





CRP was measured using a dry slide immuno-rate 
method on the OrthoFusion 5.1 F.S. analyser (Vitros 
Chemistry Products CRP slides, Ortho Clinical 
Diagnostics, Buckinghamshire, UK). As the CRP assay 
is designed for detecting raised levels of CRP it cannot 
distinguish values less than 3mg/L and all readings less 
than 3mg/L (N = 467) were assigned a value of 1.5 
mg/L. The reference interval for the assay is 10mg/L. 
Therefore, CRP levels were classified as: normal (0-
3mg/L), elevated (4-10mg/L) or acute (>10mg/L) as 
previously published [54]. Fibrinogen was measured 
using an automated Clauss assay (TOPS coagulator, 
Instrumentation Laboratory, Warrington, UK). HbA1c 
was measured in non-fasting blood using an Adams 
HA-8160 HbA1c analyzer, utilizing HPLc. The 
coefficients of variation for these biomarkers are: CRP 
= 126%, fibrinogen = 20%, HbA1c = 13%. Smoking 
status was recorded as current smoker, former smoker 
or never smoker.  
Extreme outliers were removed after visual inspection 
of the data. Two outliers were removed from HbA1c 
and one each from six metre walk time and IQ change. 
 
Isolation of peripheral blood mononuclear cells 
 
Whole blood was collected in 9ml Lithium Heparin 
tubes with PBMC isolation occurring within 72 hours of 
venepuncture. Whole blood was layered on histopaque 
and span at 400g for 30 mins at room temperature. 
Separated cells were collected and washed in RPMI 
(1% 100x Penicillin/Streptomycin and 1% L-
Glutamine) and re-suspended in 1ml freezing mix (8% 
DMSO in Fetal Calf Serum). Samples were slowly 
frozen in a ULT using a cryo freezing container for at 
least 4 hours before transferring to Liquid Nitrogen 
storage. Cell number and viability was assessed using a 
haemocytometer and trypan blue exclusion viability 
test. 
 
Generation of lymphoblastoid cell lines 
 
PBMCs underwent Epstein Barr Transformation of the 
B-lymphocyte component to generate LCLs at the 
European Collection of Cell Cultures, Public Health 
England, Porton Down, using standard methods [55]. 
Frozen cell pellets were returned to the ECRF Genetics 




RNA was extracted from LCL pellets using Qiagen 
miRNeasy kit. Cells were homogenised in Qiazol 
Buffer with chloroform added to the homogenate and 
phase separation performed at 4°C. The upper aqueous 
phase was added to 1.5x ethanol and mixed, before 
being added to the column. DNase treatment was on-
column. Eluted RNA was stored in a ULT. RNA yield 
and RIN were assessed by Agilent 2100 Bioanalyser 
and Nanodrop. 
 
Gene expression profiling 
 
Samples were amplified and biotin labelled using the 
Ambion Illumina Totalprep RNA Amplification Kit. 
The quality of the labelled cDNA was assessed on the 
Agilent Bioanalyser and genome-wide gene expression 
levels were measured on good quality samples using the 
Illumina HumanHT-12 v4 Expression BeadChip and 
scanned on an Illumina HiScan running GenomeStudio 
v2011.1. A control RNA sample was included on each 
array. The following quality control (QC) procedures 
were applied to transcript profiles. Individuals with 
signal-to-noise ratio <10 or with <9,000 transcripts 
(P<0.01) detected were excluded (n=130). Probes 
present in >20% of individuals with P<0.05 were 
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retained. The lumiExpresso command in the R package 
'lumi' [56] was used to perform variance stabilising 
transformation and quantile normalisation within a 
single step. After QC 23,031 transcripts were retained in 
781 individuals at age 70 years and 574 individuals at 
age 76 years. Transcript sequences were aligned to the 
build 38 reference genome using BLAT [57]. Only 
probes that perfectly mapped to a unique location in the 
genome were kept, with all probes mapping to a second 
position with greater than 40% identity excluded. The 
remaining transcripts were annotated to genes by 
overlapping their locations with Ensembl build 88 gene 
coordinates using BEDtools v2.26.0 [58]. 14,500 
transcripts that passed QC were successfully annotated 
to a gene. 
 
Telomere length measurement 
 
Telomere length was measured using a quantitative 
real-time polymerase chain reaction (PCR) assay [59]. 
The intra-assay coefficient of variation was 2.7% and 
the inter-assay coefficient of variation was 5.1%. Four 
internal control DNA samples were run within each 
plate to generate absolute telomere lengths and to 
correct for plate to plate variation. These internal 
controls are cell lines of known absolute telomere 
length, 6.9kb, 4.03kb, 2.0kb and 1.32kb respectively, 
whose relative ratio values (telomere starting 
quantity/glyceraldehyde 3-phosphate dehydrogenase 
starting quantity) were used to generate a regression line 
by which values of relative telomere length for the 
actual samples were converted into absolute telomere 
lengths. The correlation between relative telomere 
length and absolute telomere length was 0.8. 
Measurements were performed in quadruplicate and the 
mean of the measurements used. PCRs were performed 
on an Applied Biosystems (Pleasonton, CA, USA) 




Measurement of DNA methylation in LBC1936 has 
been described in detail previously [60]. Briefly 
genome-wide methylation levels were measured in 
DNA extracted from whole blood using the Illumina 
HumanMethylation450 BeadChips array. Quality 
control was carried out on these data to remove (i) 
probes with a low detection rate, (ii) low quality 
samples, (iii) samples with a low call rate, (iv) samples 
where there was a sex mismatch. Post-QC there were 
450,726 autosomal probes available for analysis in 920 
participants. Seventy-one of these probes were used to 
calculate DNA methylation age using the regression 
weights supplied by Hannum et al. [61]. 353 of these 
probes were used to calculate DNA methylation age 
using the regression weights supplied by Horvath et al 
[62]. Methylation age acceleration for both the Hannum 
and the Horvath methylation ages was calculated by 
regressing DNA methylation age on chronological age 




Expression change between ages 70 and 76 years 
A paired t-test was used to investigate the difference in 
the expression of each transcript between ages 70 and 
76 years for the 434 individuals with expression 
measured at both ages. Adjustment was made for plate 
and batch. A Bonferroni corrected p value of 
0.05/ntranscripts = 0.05/23031 =2.17x10-6 was used to 
indicate statistical significance. All genes were entered 
into a Gene Ontology (GO) enrichment analysis, ranked 
by p value of the transcript with the lowest p value, for 
biological processes using the Gene Ontology 
enRIchment anaLysis and visuaLizAtion tool 
(GORILLA) [63, 64]. Next, separate analyses were 
performed for genes where expression levels increased 
and for genes where expression levels decreased. No p 
value cut off was used to select genes that were entered 
into the GO enrichment analyses. A Pearson correlation 
was calculated for each transcript at age 70 and 76 
years, controlling for plate and batch. 
 
A heatmap of gene expression profiles across 
individuals and waves was plotted using the 
ComplexHeatmap package in R [65]. Plotting was 
restricted to genes significantly differentially expressed 
between waves across the 434 individuals with 
expression data at both timepoints. Both rows and 
columns of the heatmap were scaled to a mean of 0 and 
standard deviation of 1 prior to plotting. K means 
clustering with k set to two was used to separate genes 
into those going up and down between timepoints and 




Power calculations were performed using the pwr R 
package [67, 68]. Linear regression models were used to 
test the association of gene expression at age 70 years 
with gf, IQ change between the ages of 11 and 70 years, 
six metre walk time, FEV1, grip strength, CRP, 
fibrinogen, HbA1c, smoking status (current versus 
never and former versus never), telomere length and 
methylation age acceleration (Hannum and Horvath), 
adjusting for age, sex, batch and plate (N=665 to 781). 
Grip strength, six metre walk time and FEV1 were also 
adjusted for height. Expression of each gene was the 
outcome variable in all models. A Bonferroni corrected 
p value of 2.17x10-6 was used to indicate statistical 
significance. Linear regression analyses were performed 
in R. The most significant transcripts for the top 10 
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genes associated with muscle strength in [34] and 
smoking status (current versus never and former versus 




Mortality status was obtained from data linkage from 
the National Health Service Central Register, provided 
by the General Register Office for Scotland (now 
National Records of Scotland). Cox proportional 
hazards regression models were used to test the 
association between gene expression and mortality, 
adjusting for age at sample collection, sex, batch, and 
plate. Survival analyses were performed in R [68] using 
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